UCLA researchers, in global collaboration, gain new understanding of brain architecture of autism, schizophrenia
Since the completion of the groundbreaking Human Genome Project in 2003, researchers have discovered changes to hundreds of parts of DNA, called genetic variants, that are associated with autism spectrum disorder, schizophrenia and other psychiatric diseases. Now, a new, large-scale study has linked many of those changes in DNA to their molecular effects in the brain, revealing for the first time mechanisms behind those diseases.
In 10 studies published today in Science and two related journals, UCLA researchers and collaborators from more than a dozen other institutions around the world provide a comprehensive data set on the molecular workings of the brain. The findings offer a roadmap for development of a new generation of therapies for psychiatric conditions.
“This work provides several missing links necessary for understanding the mechanisms of psychiatric diseases,” said Dr. Daniel Geschwind, a senior author of two of the papers, and the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics at the David Geffen School of Medicine at UCLA.
During the past decade, scientists have compared the genetics of people with psychiatric diseases with those of healthy individuals, seeking genes that have different sequences between the two groups. Often, however, the findings raised more questions than answers. Scientists not only discovered genes linked to the diseases, but they also uncovered hundreds of areas of DNA found in between genes, called regulatory DNA, that also seemed to have an association.
Scientists know those sections of DNA can control when, where and how genes are turned on and off. But figuring out which regulatory region affect which genes — and therefore the RNA and proteins encoded by those genes — is not straightforward.
In 2015, researchers from UCLA and other institutions from around the world came together in a multidisciplinary group called the PsychENCODE Consortium to study in more detail the brain’s regulatory DNA. An earlier project, known as ENCODE, already had uncovered the roles of sections of regulatory DNA, but it was clear that those roles might be different in the brain than in other organs.
To date, PsychENCODE has analyzed not just genetic variants linked to psychiatric diseases, but also patterns of RNA and proteins in 2,188 brain tissue samples from people with and without psychiatric disorders.
In one of the new papers, Geschwind and collaborators write that the new data helps explain the roles of tens of thousands of sections of regulatory DNA in affecting RNA and proteins in the brain. The data also reveals which genes are most often expressed at the same time as each other, suggesting new biological processes and pathways. The data set — essentially a detailed model of the molecular workings of the human brain — is now available to other scientists as a starting point for research on the mechanisms of disease and potential drug targets.
“This resource is so vast that you can start by choosing an interesting disease-associated genetic variant and begin digging into that and discovering how it impacts molecular networks in the brain,” Geschwind said. “Having robust data of this scope provides a foundation for countless new studies.”
In a second paper, Geschwind, first author Dr. Michael Gandal, assistant professor of psychiatry and biobehavioral sciences at the Geffen School of Medicine, and other collaborators studied nearly 1,700 samples of brain tissue from multiple brain banks around the country; they discovered thousands of RNA molecules that are either spliced differently — with different sections of genetic material — or present at higher or lower levels in the brains of people with autism spectrum disorder, schizophrenia and bipolar disorder.
“You can’t look at the brain under a microscope and see substantial differences in these disorders,” Gandal said. “But we’ve now shown that if you look finely at patterns of how genes are expressed, you see pathways [the communication paths that neurons travel] that are clearly dysregulated.”
Among the surprises in the data is that altered levels of RNA appear to be linked to changes in the brain’s immune system in people with schizophrenia, autism spectrum disorder and bipolar disorder.
The study also showed the importance of considering which individual cell types within the brain were involved when parsing the RNA data. In some cases, alternately spliced RNA was linked to disease but only when the RNA was found in certain cell types and not others. Finally, new genes were implicated in the diseases based on the RNA results; five were linked to autism spectrum disorder, 11 to bipolar disorder, and 56 to schizophrenia.
In addition to the compelling findings already revealed based on the new data, Gandal said he is even more optimistic about what the data will help researchers do in the future.
“This is the tip of the iceberg,” Gandal said. “The ability to compile together 2,000 brains has been revolutionary in terms of revealing new genetic mechanisms, but it also points to how much we don’t know.”
The Latest on: Psychiatric diseases
via Google News
The Latest on: Psychiatric diseases
- Schumer pushes for $5B in federal funds be immediately released to increase mental health accesseson April 11, 2021 at 1:07 pm
Mental illness is no different than a physical illness and ... On top of so many people losing their jobs, businesses, and financial security, along with facing a deadly disease that has killed about ...
- Hyderabad: Depression, anxiety linked to Parkinson's disease?on April 11, 2021 at 11:25 am
Depression and anxiety could be the symptoms leading to Parkinson's disease, says doctors on the occasion of World Parkinson's Day on Sunday ...
- Federal COVID funds for mental health assistance need to be released now: Schumeron April 11, 2021 at 9:44 am
The federal COVID relief bill approved in March set aside $5 billion for mental health assistance, and Senate Majority Leader Chuck Schumer says that funding needs to be released ...
- Study finds 1 in 3 COVID-19 survivors have neurological or mental health disorderson April 11, 2021 at 7:24 am
It found 34% of people who had the coronavirus were diagnosed with brain or mental health disorders. Furthermore ... Dr. Mohammed Reza, an infectious disease specialist, said COVID-19 survivors have a ...
- COVID-19: 1 in 3 diagnosed with brain or mental health conditionon April 9, 2021 at 8:12 am
The largest study of its kind to date finds that 1 in 3 COVID-19 survivors received a neurological or mental health diagnosis within 6 months of the infection.
- One in three COVID-19 survivors diagnosed with brain or mental health disorder within 6 months of infection, study findson April 8, 2021 at 8:12 am
The study used more than 230,000 electronic health records of mostly U.S. COVID-19 patients looking at 14 different brain and psychiatric disorders.
- Brain diseases and psychiatric disorders ‘more common’ after Covid-19on April 8, 2021 at 1:05 am
There is a potential link between Covid-19 and subsequent mental health and neurological conditions, according to the largest study yet to look into the relationship. It found one in three Covid-19 ...
- 1 in 3 People Who Survive COVID-19 Are Left With ‘Brain Disease’ or Psychiatric Disorders, Says New Studyon April 7, 2021 at 12:08 pm
And now, there's evidence to suggest that a third of COVID-19 survivors are struggling with brain disease or other psychiatric disorders. That's the major takeaway from new research published in The ...
- Covid survivors are at higher risk of brain disease and mental health conditionson April 7, 2021 at 1:15 am
SURVIVORS of Covid-19 are at higher risk of being diagnosed with a brain disease or mental health condition within six months of their infection.
- A third of Covid-19 survivors suffer 'brain disease,' study showson April 6, 2021 at 9:28 pm
"Our results indicate that brain diseases and psychiatric disorders are more common after Covid-19 than after flu or other respiratory infections, even when patients are matched for other risk factors ...
via Bing News